Sitagliptin (DPP-4 Inhibitor)

Treatment used for 1 condition

Total Trials
91
Total Participants
80K
Avg Effectiveness
78%
Avg Safety Score
68%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.